Wells Fargo & Company »

Prosomnus shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Prosomnus (OSA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Prosomnus

Tip: Access up to 7 years of quarterly data

All positions including Prosomnus held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prosomnus by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $61 63 0.98
2023-09-30 $61 60 1.03
2023-06-30 $186 60 3.10

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Prosomnus

Forbes Financial Planning
Walleye Trading
Polar Securities
Vanguard Group
LPWM
Tradition Wealth Management
Axxcess Wealth Management
Presidio Capital Management
Hrt Financial
HBK Sorce Advisory
Creative Planning
Pnc Financial Services
Steward Partners Investment Advisory
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Prosomnus